Lisa R. Bacus Sells 11,455 Shares of CIGNA Co. (CI) Stock
CIGNA Co. (NYSE:CI) EVP Lisa R. Bacus sold 11,455 shares of the business’s stock in a transaction on Wednesday, May 24th. The stock was sold at an average price of $161.57, for a total transaction of $1,850,784.35. Following the transaction, the executive vice president now directly owns 24,753 shares in the company, valued at $3,999,342.21. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
CIGNA Co. (NYSE:CI) traded down 0.20% during mid-day trading on Friday, reaching $161.32. 1,348,799 shares of the company’s stock traded hands. CIGNA Co. has a 12 month low of $115.03 and a 12 month high of $164.88. The stock has a market capitalization of $41.30 billion, a PE ratio of 21.54 and a beta of 0.53. The firm’s 50-day moving average price is $157.20 and its 200 day moving average price is $146.78.
CIGNA (NYSE:CI) last issued its earnings results on Friday, May 5th. The health services provider reported $2.77 EPS for the quarter, topping the consensus estimate of $2.44 by $0.33. The firm had revenue of $10.39 billion during the quarter, compared to analysts’ expectations of $10.11 billion. CIGNA had a return on equity of 15.77% and a net margin of 4.71%. CIGNA’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same period last year, the business earned $2.46 earnings per share. Equities research analysts predict that CIGNA Co. will post $9.66 EPS for the current year.
TRADEMARK VIOLATION WARNING: This piece was published by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/05/26/lisa-r-bacus-sells-11455-shares-of-cigna-co-ci-stock.html.
A number of research firms have recently commented on CI. Royal Bank of Canada boosted their target price on shares of CIGNA from $172.00 to $177.00 and gave the stock an “outperform” rating in a research report on Monday, May 15th. Stifel Nicolaus boosted their target price on shares of CIGNA from $170.00 to $175.00 and gave the stock a “buy” rating in a research report on Monday, May 15th. Deutsche Bank AG boosted their target price on shares of CIGNA from $172.00 to $175.00 and gave the stock a “buy” rating in a research report on Wednesday, May 10th. Zacks Investment Research raised shares of CIGNA from a “sell” rating to a “hold” rating in a research report on Tuesday, April 11th. Finally, Jefferies Group LLC upped their price target on shares of CIGNA from $178.00 to $183.00 and gave the company a “buy” rating in a report on Monday, May 15th. Three analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. CIGNA has a consensus rating of “Buy” and a consensus price target of $167.57.
A number of hedge funds and other institutional investors have recently modified their holdings of CI. American Beacon Advisors Inc. bought a new position in shares of CIGNA during the first quarter worth about $102,000. Live Your Vision LLC bought a new position in shares of CIGNA during the third quarter worth about $113,000. Baystate Wealth Management LLC boosted its position in shares of CIGNA by 436.1% in the first quarter. Baystate Wealth Management LLC now owns 772 shares of the health services provider’s stock worth $116,000 after buying an additional 628 shares during the last quarter. Founders Capital Management bought a new position in shares of CIGNA during the first quarter worth about $117,000. Finally, Mckinley Capital Management LLC Delaware bought a new position in shares of CIGNA during the first quarter worth about $122,000. 85.65% of the stock is owned by hedge funds and other institutional investors.
CIGNA Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for CIGNA Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA Co. and related companies with MarketBeat.com's FREE daily email newsletter.